Sexual Disorders In Patients Research Articles

Metabolic acidosis and sexual dysfunction in chronic kidney disease in predialysis group: Cross-sectional study from a single center.

This study aimed to investigate the prevalence of sexual disorders in stage 2 - 5 chronic kidney disease (CKD) during predialysis and its relationship with laboratory parameters. This cross-sectional study included 110 predialysis patients and 110 healthy controls admitted to clinics. The International Index of Erectile Function (IIEF) and Female Sexual Function Index (FSFI) were used. Sexual dysfunction was detected in 76% of female patients and 31.4% of the control group, and the FSFI total and subscale scores of the patients were significantly lower than those of the control group. The frequency of erectile dysfunction in male patients and controls was 56.7% and 33.3%, respectively. The erectile function, sexual satisfaction, and overall satisfaction scores on the IIEF scale were significantly lower than those in the control group. Low glomerular filtration rate, high calcium levels, increased C-reactive protein, anemia, and metabolic acidosis in male and female patients, and testosterone deficiency in male patients were associated with sexual dysfunction. In multiple regression analysis, eGFR was the only independent variable associated with sexual dysfunction. Luteinizing hormone (LH) and prolactin levels increased as the disease progressed in men and women with sexual dysfunction, while testosterone levels decreased in male patients. Low testosterone levels were related to erectile dysfunction. The increase in parathormone and prolactin levels was related to loss of libido in the male and female patient groups. Metabolic acidosis and low eGFR appear to be the most important risk factors contributing to sexual disorders in patients with CKD.

Factors associated with sexual disorders in women followed for breast cancer

IntroductionBreast cancer is the most frequently encountered malignant tumor among women in Tunisia and in the world. The quality of sexual life of patients with breast cancer is impaired by multifactorial mechanisms.ObjectivesThe aim of our study was to determine the factors associated with sexual disorders in patients followed for breast cancer.MethodsCross-sectional analytic study including patients followed for breast cancer at the outpatient medical oncology consultation of Hadj Ali Soua regional hospital from January to March 2021. We collected sociodemographic and clinical data with an assessment of sexuality (FSFI), marital satisfaction (MAT), psychological profile (HAD) and quality of life (SF36).ResultsFifteen patients were included with a mean age of 49.87 ± 8.48 years and a mean age at diagnosis of 46.73 ± 7.55 years. At the TNM classification, 66.6% of the patients had a T1 or T2 at the time of diagnosis and 80% had an N0. All patients received a surgical intervention, which was conservative in 53.3% of cases. No patient underwent breast reconstruction. Chemotherapy and hormone therapy were prescribed in 86.7% of patients. The mean score of the FSFI questionnaire in our study was 17.25. Eleven patients (73.3%) had an FSFI score below 26.55. We found negative correlations between age and FSFI score (r=-0.622; p=0.013). We noted statistically significant negative correlations between FSFI and HAD-D (r=-0.606; p=0.017) and FSFI and HAD-a (r=-0.707; p=0.01) as well as significant correlations between FSFI and the following items: RE (r=0.84p=0.000), SF (r=0.684 p=0.005), GH (r=0.671 p=0.006) and MCS (r=0.788 p=0.000).ConclusionsFocusing on a small sample of patients followed for breast cancer, our study provides an assessment of the sexual function in its various areas and shows how sexuality is deeply intertwined with other sections of medical management.Disclosure of InterestNone Declared

Hypoactive Sexual Desire Due to Mental and Neurological Disorders

The article presents data on hypoactive sexual desire which occurs in neurotic and stress-related disorders (neurasthenia, anxiety-phobic and obsessive-compulsive disorders, including the syndrome of anxious expectation of sexual failure, dissociative disorders, adaptation disorders [prolonged depressive reaction, anxiety-depressive reaction]). In particular, characterizing sexual disorders in patients with neurasthenia, one group of authors believes that these disorders differ depending on the form of this disease (hypersthenic, hyposthenic). In their opinion, in the hypersthenic form increased excitability of the sexual sphere is observed which can lead to the appearance of various sexual disorders, including increased libido. In the hyposthenic form of neurasthenia, according to this group of authors, various hypoactive sexual manifestations can be noted, including a decrease in libido, and in addition, premature ejaculation. Another group of researchers found in patients with neurasthenia, regardless of its form, only hypofunctional sexological manifestations, as well as premature ejaculation (that is, those symptoms that were named by the first group of authors as characteristic of the hyposthenic form of neurasthenia). The article also presents data on hypoactive sexual desire which can be observed in personality disorders and character accentuations (schizoid personality disorder and character schizoid accentuation, accentuations of the cycloid, asthenoneurotic, hysteroid, unstable, psychasthenic, sensitive and infantile-dependent types); mood disorders [affective disorders] (dysthymia [depressive neurosis], bipolar disorder); schizophrenia; mental retardations; dementia due to organic brain damages; epilepsy; organic brain damages; multiple sclerosis. Clinical observations are given; these concern hypoactive sexual desire in patients with schizophrenia and organic brain damage.

Prevalence of Sexual Disorders in Patients With Rheumatoid Arthritis and Associated Factors.

IntroductionRheumatoid arthritis (RA) is a chronic and progressive pathology, present in between 0.5% and 1% of adults. Sexual disorders (SDs) occur in between 31% and 70% of all patients with RA.AimTo establish the associated risk factors and the prevalence of SDs in a group of patients with RA.MethodsAn analytical cross-sectional study was performed, evaluated with the Diagnostic and Statistical Manual of Mental Disorders-V tool. The related factors and the activity of the disease were explored. A multivariate logistic regression analysis was conducted.Main Outcome MeasureThe prevalence of SDs was 29.6%. There was an association between the presence of SDs and gender (women; odds ratio [OR]: 0.6, 95% CI: 0.4–0.8), age (OR: 1.4, 95% CI: 1.1–1.8), psychological alterations (OR: 12.1, 95% CI: 5.9–27.2), and Disease Activity Score 28 (OR: 1.6, 95% CI: 1.2–2).ResultsA total of 1,436 patients, with a median age of 56 years, were analyzed.ConclusionSDs are present in a third of patients with RA. Among the factors associated with SDs were the activity of the disease, presence of mood disorders, psychiatric disorders, alcoholism, and concomitant autoimmune pathologies. These findings suggest the necessity of a multidisciplinary approach to properly manage RA, as well as an enhancement in communication channels between the health professional team and the patient.Santos-Moreno P, Castro CA, Villarreal L, et al. Prevalence of Sexual Disorders in Patients With Rheumatoid Arthritis and Associated Factors. Sex Med 2020;8:510–516.

Сексуальная дисфункция у больных хроническим простатитом и ее коррекция

to study the frequency and type of sexual disorders in patients with chronic prostatitis (CP) and to evaluate the efficiency of Vitaprost and the biologically active complex NeuroDose in treating sexual dysfunctions. The study was conducted in 2015-2019 and consisted of two stages. At the first stage, the frequency and type of sexual disorders were evaluated in 422 patients with CP. Standard methods for examining patients with CP included Loran-Segal questionnaire of male copulative function (MCF), International Index of Erectile Function (IIEF-5), ICEF-5, criteria of premature ejaculation, Treatment Satisfaction Visual Analogue Scale of orgasm quality and Hospital Anxiety and Depression Scale (HADS). Patients received standard 6-week complex therapy for CP. After that, at the second stage, 244 patients with sexual dysfunction (premature ejaculation, decreased intensity of orgasm) received Vitaprost and the NeuroDose biocomplex for 2 months. Sexual disorders were detected in 77% of patients with CP. The main disorders were premature ejaculation (60.9%) and decreased intensity of orgasm (43.8%), which often occurred simultaneously. Two-month therapy of sexual dysfunction with Vitaprost and NeuroDose was effective in 94.3% of patients. Good results were observed in 80.3% of cases, while satisfactory results were obtained in 14% of patients. According to MCF, total copulative function increased by 46%, the duration of sexual intercourse increased from 1.1+/-0.4 min to 4.1+/-0.4 min (p<0.001) with an absence of premature ejaculation in 81.6% of patients, the intensity of orgasm increased from 3.8+/-0.4 to 8.0+/-0.5 (p<0.001) points, and the number of patients with neuropsychiatric symptoms associated mainly with sexual dysfunction decreased by 69.3%. Premature ejaculation and decreased intensity of orgasm are the most common sexual disorders in CP, and the combination of Vitaprost and dietary supplements NeuroDose is highly effective for their treatment.

Sexual dysfunctions following low anterior resection of the rectum in rectal cancer patients.

Low anterior resection of the rectum (LAR) is a treatment of choice in patients with diagnosed low rectal cancer. Rectal cancer surgery has a close relationship with the urinary-sexual organs and also with related nerves and nerve plexus. Thus, the sympathetic and parasympathetic nerves of the pelvic area may be damaged. As a result of this, the important point is the sexual function loss following rectal surgeries. The aim of the study was to investigate the sexual disorders in patients with rectal cancer who underwent LAR. In this retrospective study the sexual activity, comfort of the experience, quality of sexual life (QoSL) during 3 periods were analyzed: before surgery, a month after and half a year after surgery. Analysis of demographic characteristics, comorbidities, previous surgeries, toumor characteristics and adjuvant therapy as was performed. Most patients (64/100, 64%) expressed that LAR operation has strongly affected their QoSL, 32 patients reported the mild decrease in QoSL, while only 4 patients stated that did not experience any changes in QoSL. QoSL was assessed in 3 different periods of time: before the operation, 1 month after and 6 months after the operation (22,6±3.7 vs. 11.3±7,9 vs. 17,0±6.3; p&lt;0.0001 respectively). The decreased QoSL one and six months after the surgery were significantly lower in patients with diagnosed hypertension and higher BMI (p=0.0283). Sexual disorders after LAR for rectal cancer are often underestimated and it is very important to be aware of them. In our study, it was determined that male sex, higher BMI and hypertension are related to impair of sexual dysfunction after LAR. We observed that the most severe complaints related to sexual activity occur one month after the procedure, after 6 months in most of the patients&apos; sexual disorders were decreased approaching the initial state.

Sexual Dysfunction and Sex Hormone Abnormalities in Patients With Cirrhosis: Review of Pathogenesis and Management.

Healthy sexual function is important to maintain a good quality of life but is frequently impaired in patients with cirrhosis. The degree of sexual dysfunction appears to be linked with the degree of hepatic dysfunction. In men, sexual dysfunction can be related to the hyperestrogenism of portal hypertension and/or to decreased testosterone resulting from testicular dysfunction. In women, suppression of the hypothalamic-pituitary-gonadal axis appears to be a principal contributor, with no significant effect of portal hypertension. There is also a huge psychological barrier to break through as there is a component of depression in many patients with cirrhosis. Sexual dysfunction is often underdiagnosed in the cohort with cirrhosis. Management of sexual disorders in patients with cirrhosis can be challenging as they are often multifactorial. A multidisciplinary approach is key in managing these patients. We review the current literature on the pathogenesis of sexual dysfunction in patients with cirrhosis and propose a stepwise algorithm to better manage these patients.

Does Type 1 Diabetes Modify Sexuality and Mood of Women and Men?

Background: Sexual disorders occurring in women and men with type 1 diabetes have not been sufficiently investigated and described until now. This study attempts to evaluate sexuality in women and men. Methods: Altogether, the study comprised 115 patients with type 1 diabetes and 105 healthy people constituting the control group. All the studied persons underwent survey studies determining sexuality using the Female Sexual Function Index (FSFI-19) in women and the International Index of Erectile Function (IIEF-15) in men, and the occurrence of depression using the Beck Depression Inventory. The acceptance of illness among patients with diabetes was examined using the Acceptance of Illness Scale questionnaire. Results: In 35% of the examined women with diabetes, the study demonstrated sexual dysfunction as determined by total FSFI. The point values of all the investigated FSFI domains were significantly lower in women with diabetes than in healthy ones (p < 0.001). Erectile dysfunction occurred in 50% of the studied men with diabetes and in 23% of the control group of men (p = 0.0017). Conclusions: Type 1 diabetes leads to sexual disorders which occur in 1/3 of women and in 1/2 of men. Sexual disorders in patients with diabetes more frequently occur in men, persons with coexisting complications of diabetes, and in those with a concentration of glycated hemoglobin higher than 6.5%.

Male Sexual Disorders in Patients with Parkinson Disease: Treatment with Natural Remedies

Parkinson s disease PD is a neurodegenerative disorder caused by a progressive deterioration of midbrain dopamine neurons in the substantia nigra The incidence of PD in male is higher than that in women but psychological symptoms are as varied as the motor symptoms in both gender Psychological symptoms encompass a decrease in sexual desire with a long list of thymic cognitive behavioral and neuropsychiatric complications Their origin can be attributed to the natural course of the disease side effects of treatment or both Clinical researches are mainly focused on the dominant motor symptoms of PD but the nonmotor features of PD also need attention Sexual dysfunctions SD are one of the most neglected nonmotor symptoms in PD SD usually begin after the onset of motor disorders and many patients receiving DA agonists as treatment manifest uncontrollable sexual desire playing thus a major role in the deterioration of the life s quality of patients and their partners Research articles were retrieved from PubMed and Google using relevant keywords Overall this review emphasize on the sexual disorders widely reported in patients with PD and the types of natural products that are potential future supplementary agents in their control

Relationships of Sexual Dysfunction with Depression and Acceptance of Illness in Women and Men with Type 2 Diabetes Mellitus.

An increased prevalence of sexual disorders has been reported in patients with type 2 diabetes. The aim of this study is the assessment of the influence of the psychical condition, the concentration of glycated hemoglobin, the duration of diabetes, the body mass index, the age, and the subjective acceptance of the illness on sexual disorders occurring in women and men with type 2 diabetes. The study enrolled 215 patients (114 women and 101 men) with type 2 diabetes and 183 controls. Sexuality was determined in all of the studied subjects using: the Female Sexual Function Index (FSFI) in women and the International Index of Erectile Function (IIEF) in men. The occurrence of depression symptoms was determined using the Beck Depression Inventory (BDI), whereas the acceptance of the illness in diabetic patients using the Acceptance of Illness Scale (AIS). A sexual dysfunction was found in 68% of the studied diabetic women and 17% of controls. The point values of all the examined FSFI domains were significantly lower in women with diabetes than in controls (p < 0.001). Erectile disorders occurred in 82% of the studied men with diabetes and in 41% of the controls (p < 0.001). The point values of all the domains of FSFI and IIEF demonstrated a significantly negative correlation with the total BDI score, which was higher in patients with diabetes than in patients without diabetes, and a positive correlation with the total AIS score (p < 0.001). The occurrence of sexual dysfunction in patients with diabetes correlated with the age and the duration of diabetes. We conclude that sexual disorders in patients with type 2 diabetes demonstrate the correlation with the occurrence of depression and the acceptance of their illness. Sexual disorders in diabetic patients occur more frequently in older patients and in those with a longer duration of diabetes.

ANALYSIS OF THE CAUSES OF SEXUAL DISORDERS IN PATIENTS WITH PROSTATE CANCER AFTER SURGICAL AND COMPLEX TREATMENT

Objective: Analysis of the causes of sexual disorders in patients with prostate cancer after combination therapy. Material and Methods: 30 patients with prostate cancer were examined after 1-2 years of antitumor treatment including radical prostatectomy and/or radiation and glandular therapy. The comparative group consisted of 15 healthy men. Immuneenzyme analysis was used for detection of sexual hormone status; ultrasound and dopplergraphic methods as well as radiation method were conducted for angiographic study of pool vessels of the inner pudendal artery. Denervation disturbances in the pool of the inner sexual artery were diagnosed by the conduction of the applicative electroneuromyographic studies of the penis. Results: According to research conducted in 100% of cases within patients with prostate cancer erectile and sexual dysfunction were detected after combination therapy, which was not detected before therapy. Sporadic usage of the Vth type of phosphodiesterase inhibitors by patients with erectile dysfunction of severe form did not lead to improvement of potency. The main cause of erectile and sexual dysfunction in patients with prostate cancer was an aggressive antitumor therapy, which led to the development of stenosis in 100% of cases, occlusion in the pool of internal pudendal artery and in 100% cases to sensory-motor disorders of innervation of the penis. Maximum androgen blockade aggravated sexual dysfunctions within the patients with prostate cancer. Conclusion: Denervation and hemodynamically significant perfusion disturbances in the pool of the inner pudendal artery within the patients with prostate cancer after surgical and combination therapy lead to erectile and sexual dysfunction. The only possible mean of sexual rehabilitation of patients with prostate cancer after antitumor treatment is the endoprosthesis of penis.

Psychosexual disorders: A cross-sectional study among opioid-dependent individuals

Context: Punjab is in hold of a drug abuse-related epidemic, and the prevalence of opioid misuse is increased in the last few decades. A large-scale epidemiological data on sexual disorders among opioid users are lacking in literature. Aim: The aim of this articles was to study the prevalence of sexual disorders in patients with opioid dependence. Settings and Design: A cross-sectional study was conducted at a de-addiction clinic of a tertiary care centre from Punjab, India. Methods and Materials: A total of 109 consecutive patients attending the de-addiction clinic and fulfilling the eligibility criteria were assessed for sexual dysfunction by a predesigned, pretested, semistructured questionnaire. International Index of Erectile Function (IIEF-15) was administered to all patients to explore various aspects of sexual dysfunction. Statistical Analysis: Collected data were analyzed by SPSS version 20 using appropriate statistical test. Results: Mean age of participants was 29.9 years, 67% were married and heroin was the opioid of choice for 81.7%. Impaired sexual desire (59.6%) was the commonest psychosexual problem, followed by decreased orgasmic function (57.8%), erectile dysfunction (56.4%), decreased overall satisfaction (52.2%), and decreased intercourse satisfaction (46.7%). Conclusions: The prevalence of all types of sexual dysfunction was found to be statistically significant with more than 1 year of opioid use. These findings can be used to motivate the patients to enter a rehabilitation program at an earlier stage of opioid dependence. Opioid-dependent individuals should be thoroughly investigated for sexual dysfunction and its treatment should be made an integral part of de-addiction and rehabilitation program.

Обґрунтування удосконалення діагностики сексуальних розладів у хворих соматичного профілю на прикладі виразкової хвороби шлунка та дванадцятипалої кишки

The objective: The study and improvement of diagnosis of sexual disorders in patients of somatic profile, with ulcerative disease of the stomach (UDS) and peptic ulcer disease duodenal ulcer (DU). Patients and methods. For 3 years carried out a comprehensive examination and treatment of 130 patients with DU in remission and UDS in remission, which is observed sexual disorders; the first was 76 (58.5±4.3%) patients, second – 54 (41.5±4.3%); p&lt;0.05. They represented the main group. The comparison group included 100 male patients with DU and UDS, which were also in remission, but did not complain of sexual disorders; accordingly, they were of 66.0±4.7% and 34.0±3.3%; p&lt;0.05. Also was used a reference group (control) of 20 healthy men. All groups were matched for age (average age in the major groups – 34.0±1.7 years in the control to 32.0±4.0 years), and the first two – and duration of ulcer (average period in the history of 6.9±0.7 years). Results. The frequency of manifestations of depression in patients with DU and UDS with sexual disorders identified parameters, among which reliably allocated to mental anxiety (85.4±3.1%), depressive mood (73.1±3.8%), somatic anxiety (66.1±4.3%), reduced efficiency and activity (64.6±4.1 percent). Their combination in various embodiments burdened the situation. Exclusively in patients with peptic ulcer disease was most prevalent somatic anxiety (32.0±4.6%), depressive mood (28.0±4.5%), capacity and activity (24.0±4.2%). The majority of patients with DU and UDS with sexual disorders (60,8±4,2%) recorded a high level of personal anxiety and almost equally often low to moderate (19,2±3,4% and 20.0±3.4%, respectively). However, 93.0% of patients only with peptic ulcer were also noted its low level of expression. At the same time, among the first significantly more often observed the average level of situational anxiety (62.3±4.2%), every third - low (28.5±3.9%) and others (10.0 per cent), whereas among second - frequency dominated low level (63.0±4.9% vs 31.0±4.9% of the average and 6.0±2.3% - high). Conclusion. Justified the principle of improving the early identification of sexual disorders in men with chronic somatic diseases, for example peptic ulcer disease, the essence of which is to be included in the anamnestic and diagnostic method of two key issues, namely: the satisfaction of sexual intercourse and satisfaction with sexual life in General. Key words: gastric ulcer and duodenal ulcer, sexual dysfunction, diagnosis.

P-03-042 Use of chorionic gonadotropine treatement for prevention of sexual disorders in patients with hypogonadotropic hypogonadism after pituitary adenoma resection

Male hypogonadism is a condition in which the body does not produce enough testosterone. Testosterone is a hormone that plays a key role in masculine growth and development during puberty. Male hypogonadism is characterized by deficiency in testosterone – a critical hormone for sexual, cognitive, and body function and development. Clinically low testosterone levels can lead to infertility, muscle wasting and other sexual disorders. Low testosterone levels may be due to testicular, hypothalamic or pituitary abnormalities. 28 years old male patient attended our clinic soon after pituitary adenoma resection with the complains of decreased energy and interest, weight gain. He had no other complains. We aimed to perform all laboratory tests not to miss any releasing hormone deficiency. All hormones were within normal ranges, while Luteinizing Hormone - 0,79 mIU/mL (N 1,5-9,3) Follicle-stimulating hormone 1,33 (N 1,4-18,1) Free Testosterone 3,26 (N6,2-28,1) levels were low. So the diagnosis of hypogonadotropic hypogonadism (HH) was obvious.

Эффективность акупунктуры и фототерапии в коррекции эректильной дисфункции у больных невротической депрессией

Sexual dysfunction in men, limiting their reproductive capabilities, prevent the achievement of marital and sexual life as a couple, break the stability of marriage, adversely affect mental health, lead to the development of neurotic and depressive disorders, alcohol abuse and antisocial behaviour.&#x0D; In recent years, interest in the problem of vasculogenic erectile dysfunction has increased worldwide. But, despite this, many researchers believe that erectile dysfunction of vascular origin ranks second in frequency after disorders due to psychogenic factors.&#x0D; Therapy of sexual disorders with neurotic depression has a number of obstacles due to absence of system-structural approach to sexopathologist syndromes. It is necessary to search new possibilities of correction of sexual disorders in patients with neurotic depression.&#x0D; The purpose of this study was to develop and to justify pathogenetically the method of combined use of phototherapy and acupuncture for the correction of sexual disorders to improve the effect of treatment in men with neurotic depression.&#x0D; 80 patients with neurotic depression and erectile dysfunction prior to the application of medical facilities and at the end of treatment were examined. The results of treatment were: restoration of sexual function, decrease or disappearance of neurasthenic complaints (irritability, fatigue, headaches, dyssomnia, psycho-emotional, vegetative-vascular disorders, and others), normalization of libido and paraclinical data (psychological testing, electrophysiological parameters).&#x0D;

THU0592-HPR Precipitating, Predisposing and Maintenance Factors Associated with Sexual Disorders in Patients with Rheumatoid Arthritis

BackgroundSexuality is an important dimension of personality and human body, therefore any involvement in this area should be considered as important. Sexual disturbances in rheumatoid arthritis (RA) patients are poorly...

AB0828-HPR Psychological and sexual disorders in patients with rheumatoid arthritis and correlation with disease activity

BackgroundEmotional stability and sexual life are important dimensions of personality, therefore any involvement in these areas should be considered as important. Psychological and sexual disorders in rheumatoid arthritis (RA) are...

AB0419 Psychological and sexual disorders in patients with rheumatoid arthritis and correlation with disease activity

BackgroundEmotional stability and sexual life are important dimensions of personality, therefore any involvement in these areas should be considered as important. Psychological and sexual disorders in rheumatoid arthritis (RA) are...

AB1431-HPR Factors associated with sexual disorders in patients with rheumatoid arthritis and relationship with disease activity

BackgroundSexuality is an important dimension of personality and human body, therefore any involvement in this area should be considered as important. Rheumatoid arthritis (RA) causes inability in various performance areas...

The evaluation of sexual dysfunction in male patients with migraine and tension type headache

BackgroundErectile dysfunction (ED), defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance, is a common condition. The psychological, hormonal, neurogenic and arterial pathologies, medications, chronic diseases have been reported in the etiology of the ED. This paper aims to study sexual dysfunction in the male patients with migraine and Tension type headache (TTH).Methods30 migraine cases (Group M), 31 TTH cases (Group T) and 30 control cases (Group C) were included in the study. Patients were evaluated with medical history, physical examination, body mass index (BMI), Beck Depression Inventory, biochemical analysis and hormone profiles. ED was evaluated via International Index of Erectile Function Scale (IIEF). In statistical analysis, variant analysis, post-hoc tukey test, Pearson correlation test, t-test, and fisher's exact chi-square test were used.ResultsThe patients' mean age was 34.96+/−1.30, 35.54+/−1.52 and 32.26+/−1.38 for group M,T and C, respectively. There was no significant difference between the groups in terms of testosterone levels. Mean IIEF scores was 19.83+/−2.2, 20.39+/−1.35 and 27.83+/−0.34 in groups M,T,C. When M and T groups were compared with group C, there were significant differences, and there was no statistical difference when T and M groups were compared to each other. Beck Depression Scores were not significantly different in groups M, T and C.ConclusionIn this study, it was shown that, migraine and TTH affects the sexual functions negatively in male patients. Chronic diseases may cause sexual disorders in patients because of despair, guilt, and fear of death or pain. Our results suggest that, along with the effect of chronic disease and pain, there must be other complicated factors exist causing the development of SD in patients with migraine and TTH.